Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2600120375Phase 4Not yet recruiting
Phase 4, randomised trial of bupivacaine in upper extremity fracture (2 arms), sponsored by Anshan Central Hospital. Primary endpoints: Pain score and Sleep quality (primary). Planned start Mar 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2600120375.